Supplement maker walks fine legal line
677772
Just three years after Ohio salesman Steve Warshak started selling penis enlargement pills out of a spare room in his home, his company rakes in more than $200 million a year on unproven palliatives
339767
A medical product used to treat both  male hair loss and prostate problems has been added to the list  of banned drugs for athletes.
23193
WASHINGTON Two Chinese herbal supplements are being recalled because they contain a carcinogen linked to kidney disease. Kingsway Trading Company of Brooklyn, New York, is recalling its dietary pills Double
685744
The Medicines Company reacquires its own drug.
408058
The widow and son of a Texas man who was taking a GlaxoSmithKline Plc diabetes drug at the time of his fatal heart attack has sued the drugmaker, claiming that it failed to warn of the drug's heart risks, according to court papers.
564566
A legal battle is shaping up in California involving a Chinese startup that makes equipment used to produce semiconductors.
287612
Pulling an application for Iressa from the EU makes the drug a has-been.
710690
Is the company's push into nutritional supplements a wise move?
752647
One of the pioneers of offshoring tries to cash in.
665855
Refilling, reselling cartridges doesn't violate patents - Tokyo court
124022
NEW YORK - A man has sued the maker of the health drink Boost Plus, claiming the vitamin-enriched beverage gave him an erection that would not subside and caused him to be hospitalized.
481184
A New Jersey man has filed a false  advertising lawsuit against a maker of herbal penis enlargement  pills, alleging the medicine does not fulfill its promises, the  plaintiff's lawyer said on Monday.
687773
The county that is home to the Food and Drug Administration took a first step yesterday toward buying prescription drugs from Canada, despite FDA warnings that such a practice would be illegal.
483009
Jazz Pharmaceuticals, maker of Xyrem, said it had improperly promoted the drug for unapproved uses. The company will pay $20 million in fines.
137099
The pharmaceutical files another marketing application.
122422
The maker of generic drugs gets sued twice in one week.
763972
GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research) has got off more lightly than expected in a high-profile legal clash